-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Petros Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2020 to 2023.
- Petros Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$1.13M, a 51.6% decline year-over-year.
- Petros Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$7.63M, a 40.4% increase from 2022.
- Petros Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$12.8M, a 7.89% decline from 2021.
- Petros Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$11.9M, a 22.5% increase from 2020.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)